In another study, G129R-hPRL was fused to endostatin, and was shown to inhibit PRL-induced signaling in T47D breast cancer cells, while further suppressing HUVEC cell proliferation, tube formation, and tumor formation of mouse 4T1 cells in vivo (51, 52). Here, PRL is linked to breast cancer.